New drug shows dramatic results in reducing lung cancer tumours
June 23rd, 2010 - 4:23 pm ICT by ANIWashington, June 23 (ANI): A new drug could be instrumental in shrinking tumours in lung cancer patients, according to a new study.
The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumours in some patients during Phase I and II clinical trials.
Phase I/II clinical trials demonstrated that 57 percent of patients had their tumours reduced and at eight weeks of the treatment, 87 percent showed disease stabilization.
“The Phase III clinical trials will be critical in determining if this drug goes to market,” said Lyudmila Bazhenova, MD, assistant clinical professor at UC San Diego School of Medicine and a member of the Moores UCSD Cancer Center.
In some patients with non-small cell lung cancer (NSCLC), fusion of anaplastic lymphoma kinase (ALK) gene and EML4 gene promotes lung cancer cell growth, especially if they have adenocarcinoma subtype of lung cancer. Crizotinib inhibits the enzyme, allowing the cancer cells to die off. (ANI)
- 'Smart' lung cancer drug shows promise - Oct 28, 2010
- New drug shows promise against certain lung cancers - Oct 29, 2010
- Targeted drug therapy shows promise against deadly form of lung cancer - Nov 02, 2010
- TTF therapy, chemo combo 'increase survival for lung cancer patients' - Oct 11, 2010
- Cheap, fast test identifies aggressive type of lung cancer in never-smokers - Feb 26, 2011
- Silencing 'hedgehog' molecule halts cancer - Jun 06, 2011
- Scientists stumble upon 'stop cancer' gene - Nov 16, 2011
- Two significant advances in treating lung cancer announced - Aug 09, 2009
- New discovery shows promise against non-small cell lung cancer - Dec 04, 2010
- Gene set shows which patients benefit from chemo after surgery - Sep 08, 2010
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Shark cartilage does not improve lung cancer survival - May 27, 2010
- Gene mutations help leukemia drug fight squamous cell lung cancer - Apr 04, 2011
- Skin rash linked to better outcomes for patients with lung cancer - Dec 20, 2010
- Link between breast implants and rare form of cancer confirmed - Apr 20, 2011
Tags: assistant clinical professor, cancer cell growth, cancer cells, cancer center, cancer tumours, cell lung cancer, clinical trials, disease stabilization, dramatic results, lung cancer, lung cancer patients, lyudmila, moores, non small cell lung cancer, pfizer, phase iii, school of medicine, small cell lung cancer, subtype, uc san diego